08:00 , Jan 15, 2007 |  BC Week In Review  |  Company News

pSivida Ltd., Auritec deal

Auritec's IP holding company, Faber Research LLC, received exclusive rights to use PSD's Durasert, Zanisert and Co-Drug delivery technologies to develop and commercialize treatments for malaria, HIV/AIDS, influenza, tuberculosis, osteomyelitis and diseases of the ear....